These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11355694)

  • 1. Up-Regulation of ninjurin expression in human hepatocellular carcinoma associated with cirrhosis and chronic viral hepatitis.
    Kim JW; Moon AR; Kim JH; Yoon SY; Oh GT; Choe YK; Choe IS
    Mol Cells; 2001 Apr; 11(2):151-7. PubMed ID: 11355694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.
    Jiang J; Gusev Y; Aderca I; Mettler TA; Nagorney DM; Brackett DJ; Roberts LR; Schmittgen TD
    Clin Cancer Res; 2008 Jan; 14(2):419-27. PubMed ID: 18223217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.
    Livni N; Eid A; Ilan Y; Rivkind A; Rosenmann E; Blendis LM; Shouval D; Galun E
    Cancer; 1995 May; 75(10):2420-6. PubMed ID: 7736384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
    Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
    Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma.
    Chung YH; Kim JA; Song BC; Lee GC; Koh MS; Lee YS; Lee SG; Suh DJ
    Cancer; 2000 Sep; 89(5):977-82. PubMed ID: 10964327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.
    Wang Z; Gou W; Liu M; Sang W; Chu H; Zhang W
    Med Sci Monit; 2015 Oct; 21():3209-15. PubMed ID: 26494212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma.
    Li G; Cai G; Li D; Yin W
    Postgrad Med J; 2014 Feb; 90(1060):106-12. PubMed ID: 24243965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
    Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H
    Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Expressions of Somatostatin and Cycloxygenase-2 in Chronic Hepatitis, Hepatic Cirrhosis, Precancerous Lesion and Hepatocellular Carcinoma].
    Xie YM; Li X; Yan LN; Wei B; Wang CH; Tang CW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):710-6. PubMed ID: 26619541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular carcinoma and liver metastases.
    Chen GG; Lai PB; Chak EC; Xu H; Lee KM; Lau WY
    Cancer Lett; 2001 Oct; 172(1):75-82. PubMed ID: 11595132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis.
    Mamiya T; Yamazaki K; Masugi Y; Mori T; Effendi K; Du W; Hibi T; Tanabe M; Ueda M; Takayama T; Sakamoto M
    Lab Invest; 2010 Sep; 90(9):1339-45. PubMed ID: 20531292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma.
    Park BC; Huh MH; Seo JH
    J Hepatol; 1995 Mar; 22(3):286-94. PubMed ID: 7608479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
    Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
    Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of P21 and P15 proteins in liver tissue of chronic viral hepatitis and hepatocellular carcinoma and their relation to cell apoptosis.
    Wang Y; Wang L; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):157-9. PubMed ID: 11503050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Xie Y; Yao Q; Butt AM; Guo J; Tian Z; Bao X; Li H; Meng Q; Lu J
    Cancer Biol Ther; 2014 Sep; 15(9):1248-55. PubMed ID: 24971953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Kwon SH; Jeong SW; Jang JY; Lee JE; Lee SH; Kim SG; Kim YS; Cho YD; Kim HS; Kim BS; Jin SY
    Clin Mol Hepatol; 2012 Sep; 18(3):287-94. PubMed ID: 23091809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of BCR protein associated with oncogenesis in human hepatocellular carcinoma.
    Miyazaki Y; Mitsuma T; Ichida T; Odazima H; Ishihara K; Asakura H
    Dig Dis Sci; 1997 May; 42(5):927-37. PubMed ID: 9149044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
    El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
    MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.